p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas

Area of Science:

• Oncology
• Molecular Pathology
• Head and Neck Cancer Research

Background:

• Verrucous carcinoma (VC) is a low-grade malignancy often linked to tobacco and human papillomavirus (HPV).
• The underlying pathobiology and molecular genetic alterations in VC remain underexplored.
• Understanding these alterations is crucial for diagnosing and managing VC.

Purpose of the Study:

• To investigate the expression of p53, Rb, and cyclin D1 in oral verrucous carcinoma.
• To identify potential molecular genetic changes associated with VC development.
• To correlate these molecular findings with the low-grade malignant nature of VC.

Main Methods:

• Immunohistochemistry was performed on 29 formalin-fixed, paraffin-embedded oral VC cases.
• Antibodies against p53 (CM-1), Rb (Rb-WL-1), and cyclin D1 were utilized.
• The avidin-biotin immunoperoxidase technique was employed for protein detection.

Main Results:

• p53 protein accumulation was observed in 15 out of 29 (51.7%) VC cases.
• No alterations in Rb protein expression were detected in any of the studied cases.
• Cyclin D1 overexpression was found in 11 out of 18 (61.1%) analyzed VC cases.

Conclusions:

• Frequent p53 protein accumulation suggests possible p53 gene mutations in verrucous carcinoma.
• Overexpression of cyclin D1, alongside intact Rb, indicates potential Rb inactivation mechanisms, possibly involving cyclin D1 or HPV.
• These findings contribute to understanding the molecular basis of verrucous carcinoma.